Mutual of America Capital Management LLC cut its stake in shares of Molina Healthcare, Inc (NYSE:MOH – Free Report) by 5.8% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 6,470 shares of the company’s stock after selling 398 shares during the period. Mutual of America Capital Management LLC’s holdings in Molina Healthcare were worth $2,131,000 at the end of the most recent quarter.
Other large investors also recently added to or reduced their stakes in the company. Amalgamated Bank raised its position in shares of Molina Healthcare by 0.3% in the first quarter. Amalgamated Bank now owns 11,580 shares of the company’s stock valued at $3,814,000 after buying an additional 33 shares during the last quarter. Deseret Mutual Benefit Administrators grew its holdings in shares of Molina Healthcare by 60.7% in the first quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company’s stock valued at $30,000 after purchasing an additional 34 shares during the period. JLB & Associates Inc. grew its holdings in shares of Molina Healthcare by 0.3% in the first quarter. JLB & Associates Inc. now owns 10,626 shares of the company’s stock valued at $3,500,000 after purchasing an additional 36 shares during the period. Angeles Investment Advisors LLC grew its holdings in shares of Molina Healthcare by 5.4% in the fourth quarter. Angeles Investment Advisors LLC now owns 838 shares of the company’s stock valued at $244,000 after purchasing an additional 43 shares during the period. Finally, Coldstream Capital Management Inc. grew its holdings in shares of Molina Healthcare by 2.1% in the fourth quarter. Coldstream Capital Management Inc. now owns 2,346 shares of the company’s stock valued at $683,000 after purchasing an additional 48 shares during the period. 98.50% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Molina Healthcare
In other news, Director Richard M. Schapiro sold 669 shares of the stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the transaction, the director directly owned 11,244 shares in the company, valued at approximately $3,603,702. This represents a 5.62% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the company’s stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the sale, the chief executive officer directly owned 257,715 shares in the company, valued at approximately $82,484,262.90. This represents a 25.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.
Molina Healthcare Stock Down 10.7%
Molina Healthcare (NYSE:MOH – Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping analysts’ consensus estimates of $5.96 by $0.12. The firm had revenue of $11.15 billion during the quarter, compared to analysts’ expectations of $10.86 billion. Molina Healthcare had a return on equity of 28.38% and a net margin of 2.81%. Molina Healthcare’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $5.73 EPS. Sell-side analysts expect that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on MOH. Guggenheim began coverage on shares of Molina Healthcare in a research report on Wednesday, April 9th. They set a “neutral” rating on the stock. Mizuho set a $330.00 target price on shares of Molina Healthcare and gave the company an “outperform” rating in a report on Friday, July 11th. Wall Street Zen cut shares of Molina Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, June 29th. Truist Financial dropped their target price on Molina Healthcare from $400.00 to $335.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, Sanford C. Bernstein assumed coverage on Molina Healthcare in a report on Tuesday, April 22nd. They issued an “outperform” rating and a $414.00 target price on the stock. Eleven investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $347.57.
Read Our Latest Report on Molina Healthcare
About Molina Healthcare
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles
- Five stocks we like better than Molina Healthcare
- What is a SEC Filing?
- PepsiCo Bottomed Out—Time to Chugalug This Blue-Chip Buy?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Is J.B. Hunt Stock a Sleeping Giant Heading Into 2026?
- What is a penny stock? A comprehensive guide
- These 3 Rare Earth Stocks Are Surging Alongside MP Materials
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.